MERCK Kommanditgesellschaft auf Aktien
MER
Rank in Stocks
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Share Price
$171.67
Last synced: 2026-07-13
Market Cap
$74.64B
Change (1 day)
0.00%
Change (1 year)
-
Country
DE
Trade MERCK Kommanditgesellschaft auf Aktien (MER)
Category
Healthcare
Earnings for MERCK Kommanditgesellschaft auf Aktien (MER)
Earnings in 2026 TTM: 0
According to MERCK Kommanditgesellschaft auf Aktien latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for MERCK Kommanditgesellschaft auf Aktien from 2002 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2025 | $3.88B | -15.61% |
| 2022 | $4.60B | 3.06% |
| 2021 | $4.46B | 39.31% |
| 2020 | $3.20B | 64.54% |
| 2019 | $1.95B | 15.95% |
| 2018 | $1.68B | -37.09% |
| 2017 | $2.67B | 17.75% |
| 2016 | $2.27B | 40.42% |
| 2015 | $1.61B | -14.32% |
| 2014 | $1.88B | -1.34% |
| 2013 | $1.91B | 104.18% |
| 2012 | $935.24M | -15.11% |
| 2011 | $1.10B | -4.30% |
| 2010 | $1.15B | 65.07% |
| 2009 | $697.43M | -12.95% |
| 2008 | $801.20M | -594.25% |
| 2007 | $-162.10M | -109.67% |
| 2006 | $1.68B | 58.74% |
| 2005 | $1.06B | -18.97% |
| 2004 | $1.30B | 144.81% |
| 2003 | $532.17M | 23.21% |
| 2002 | $431.92M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
